Two neolignan compounds, magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl, 1)
and honokiol (5,5'-diallyl-2,4'-dihydroxybiphenyl, 2), were isolated from t
he stem bark of Magnolia obovata and evaluated for antifungal activity agai
nst various human pathogenic fungi. Compound 1 and 2 showed significant inh
ibitory activities against Trichophyton mentagrophytes, Microsporium gypseu
m, Epidermophyton floccosum, Aspergillus niger, Cryptococcus neoformans, an
d Candida albicans with minimum inhibitory concentrations (MIC) in a range
of 25-100 mu g/ml. Therefore, compound 1 and 2 could be used as lead compou
nds for the development of novel antifungal agents.